JPH01500265A - キシロメタゾリン含有薬物学的製剤 - Google Patents

キシロメタゾリン含有薬物学的製剤

Info

Publication number
JPH01500265A
JPH01500265A JP62503730A JP50373087A JPH01500265A JP H01500265 A JPH01500265 A JP H01500265A JP 62503730 A JP62503730 A JP 62503730A JP 50373087 A JP50373087 A JP 50373087A JP H01500265 A JPH01500265 A JP H01500265A
Authority
JP
Japan
Prior art keywords
xylometazoline
oil
pharmaceutical preparations
preparations containing
triglyceride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62503730A
Other languages
English (en)
Japanese (ja)
Inventor
レーベル，クラウス‐デイーター
Original Assignee
アシエ　アクチエンゲゼルシヤフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アシエ　アクチエンゲゼルシヤフト filed Critical アシエ　アクチエンゲゼルシヤフト
Publication of JPH01500265A publication Critical patent/JPH01500265A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP62503730A 1986-07-18 1987-06-24 キシロメタゾリン含有薬物学的製剤 Pending JPH01500265A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3624624.7 1986-07-18
DE19863624624 DE3624624A1 (de) 1986-07-18 1986-07-18 Xylometazolinhaltige pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
JPH01500265A true JPH01500265A (ja) 1989-02-02

Family

ID=6305642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62503730A Pending JPH01500265A (ja) 1986-07-18 1987-06-24 キシロメタゾリン含有薬物学的製剤

Country Status (12)

Country Link
EP (1) EP0282495B1 (da)
JP (1) JPH01500265A (da)
AU (1) AU7547387A (da)
DE (2) DE3624624A1 (da)
DK (1) DK149588A (da)
ES (1) ES2004454A6 (da)
FI (1) FI881271L (da)
GR (1) GR871134B (da)
IL (1) IL83177A0 (da)
PT (1) PT85350B (da)
WO (1) WO1988000473A1 (da)
ZA (1) ZA875281B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1011016C2 (nl) * 1999-01-13 2000-07-14 Dagra Pharma Bv Neusspray op basis van xylometazoline en kamille-extract.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung

Also Published As

Publication number Publication date
EP0282495B1 (de) 1991-06-19
PT85350A (de) 1987-08-01
ES2004454A6 (es) 1989-01-01
DE3770939D1 (de) 1991-07-25
EP0282495A1 (de) 1988-09-21
FI881271A7 (fi) 1988-03-17
DK149588D0 (da) 1988-03-18
FI881271A0 (fi) 1988-03-17
AU7547387A (en) 1988-02-10
GR871134B (en) 1987-11-20
FI881271L (fi) 1988-03-17
IL83177A0 (en) 1987-12-31
DK149588A (da) 1988-03-18
WO1988000473A1 (fr) 1988-01-28
DE3624624A1 (de) 1988-01-28
PT85350B (de) 1989-10-16
ZA875281B (en) 1988-03-30

Similar Documents

Publication Publication Date Title
Allen et al. Selenium sulfide: adjunctive therapy for tinea capitis
EA199900991A1 (ru) Медицинские аэрозольные препараты
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
ES2073164T3 (es) Liposomas heterovesiculares.
DE3686483D1 (de) Arzneimittel.
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
MX9204627A (es) Compuestos 1-acilpiperidina, procedimiento para su preparacion y composicion farmaceutica que los comprende.
DE69111582D1 (de) 1,4-Disubstituierte Piperazine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ATE283047T1 (de) Verwendung von ibudilast zur herstellung eines arzneimittels zur behandlung multiple sklerose
JP2018083805A (ja) 水性眼科組成物
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
RU2218334C2 (ru) Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцин-10-олы и фармацевтическая композиция на их основе
JPH01500265A (ja) キシロメタゾリン含有薬物学的製剤
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
SE8600658D0 (sv) Novel composition of matter
ATE55248T1 (de) Arzneimittelkombination.
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
ATE40793T1 (de) Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen.
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
FR2374036A1 (fr) Compositions pharmaceutiques contenant de la 3-phenoxypyridine
AR013132A1 (es) Un compuesto derivado de tetrahidroimidazo[2,1-a]isoquinolina, su uso y una formulacion farmaceutica que lo comprende.
FR2432316A1 (fr) Nouveaux medicaments contenant, a titre de substance active, des composes de type benzenesulfone, nouveaux composes de ce type et procede pour leur preparation
AT342761B (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung